4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-006735
Options or other derivatives
- Chief Operating Officer acquired 84,026 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/rdgdoc.xml…